Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Sugar Land, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Tvardi Therapeutics, Inc. has filed 801 SEC EDGAR filings since 06 Dec 2005

SEC filing history

Showing 551-575 of 796 matching filings.

Per page
25
Current page
23
8-K File 001-36279

8-K

Filing date
17 Jul 2018
Reporting date
17 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-216657

424B5

Filing date
17 Jul 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jul 2018
Reporting date
10 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jul 2018
Reporting date
02 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36279

8-K

Filing date
27 Jun 2018
Reporting date
27 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jun 2018
Reporting date
06 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jun 2018
Reporting date
06 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jun 2018
Reporting date
06 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36279

8-K

Filing date
08 Jun 2018
Reporting date
06 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jun 2018
Reporting date
01 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 May 2018
Reporting date
23 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36279

8-K

Filing date
23 May 2018
Reporting date
23 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36279

8-K

Filing date
23 May 2018
Reporting date
17 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36279

8-K

Filing date
09 May 2018
Reporting date
09 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36279

DEFA14A

Filing date
26 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36279

DEF 14A

Filing date
26 Apr 2018
Reporting date
06 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-223726

S-8

Filing date
16 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36279

8-K

Filing date
15 Mar 2018
Reporting date
15 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Mar 2018
Reporting date
09 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Mar 2018
Reporting date
09 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Mar 2018
Reporting date
09 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Mar 2018
Reporting date
09 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36279

FORM 8-K

Filing date
12 Mar 2018
Reporting date
06 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .